Is berberine bad for your kidneys or liver?

The myth and the verdict

The myth is simple: because berberine is metabolically active, it must be hard on your kidneys or liver. The verdict is mostly false for healthy adults, partially unresolved for higher-risk groups. In short human trials, berberine has not shown a consistent pattern of kidney or liver injury. In liver-focused studies, especially non-alcoholic fatty liver disease research, the signal often points the other way: liver enzymes and metabolic markers improve rather than worsen.1, 3

That does not make berberine risk-free. It means the common internet version of the claim is too blunt. The evidence does not support “berberine damages kidneys and liver” as a general rule. It supports a narrower warning: if you already have advanced kidney disease, active liver disease, are pregnant or breastfeeding, are giving it to an infant, or take medications with narrow safety margins, do not treat berberine like a harmless food.²

What the human evidence shows

The best liver-specific evidence comes from trials and meta-analyses in people with fatty liver disease. A 2024 systematic review and meta-analysis of berberine for non-alcoholic fatty liver disease reported a favorable safety profile, with adverse events mainly described as mild gastrointestinal symptoms, while liver-related metabolic outcomes improved.1 A randomized clinical trial in NAFLD also monitored liver enzymes and metabolic markers during berberine treatment, using those labs as part of the safety and efficacy assessment rather than finding a clear liver injury signal.3

There is also a separate trial of berberine ursodeoxycholate, a drug-like berberine formulation, in fatty liver disease. It is not the same as buying standard berberine capsules, but it matters because it tests a berberine-containing intervention in a population where liver safety is central. The trial was designed as an 18-week randomized, double-blind, placebo-controlled study in patients with fatty liver disease, and it did not establish a broad signal that berberine exposure is inherently liver-toxic.5

Kidney evidence is less satisfying. Most berberine studies are not designed primarily to answer, “Does this harm kidneys?” They often include creatinine or related chemistry panels as safety markers. A 30-day randomized crossover human study that gave 1,000 mg per day tracked safety markers including AST, ALT, bilirubin, creatinine, glucose, HbA1c, and electrolytes. That kind of study is reassuring for short exposure in monitored adults, but it cannot answer long-term safety in people with advanced chronic kidney disease.⁴

So the honest read is this: the human data do not show routine kidney or liver harm at commonly studied doses, but the kidney evidence is more about absence of an obvious short-term signal than proof of long-term safety.

The mechanism people worry about

The concern is not irrational. Berberine is not inert. It interacts with glucose and lipid metabolism, affects gut and liver signaling pathways, and is transformed into multiple metabolites. Pharmacokinetic research shows that berberine and its metabolites are recovered through feces, bile, and urine, which means liver and kidney handling are part of the compound’s biology.6

The myth takes that true statement and overextends it. “Processed by the liver” does not automatically mean “damages the liver.” “Detected in excretion pathways” does not automatically mean “toxic to the kidneys.” Human safety depends on dose, formulation, duration, baseline organ function, age, pregnancy status, and drug interactions. Those are exactly the areas where routine supplement marketing tends to get vague.

There is also a medication-interaction issue. Berberine can interact with drug transporters and metabolic pathways, which is one reason NCCIH advises caution and highlights that people should talk with a clinician before using it, especially when taking medicines or when pregnant or breastfeeding.² That is different from saying berberine directly injures the liver or kidneys. A compound can be organ-safe for many users and still be risky in the wrong medication context.

Why the myth persists

This myth persists because both sides oversell. Supplement marketing often frames berberine as a natural answer for blood sugar, cholesterol, weight, and fatty liver. Critics then respond by treating “natural but pharmacologically active” as if it automatically means organ damage. Both shortcuts skip the evidence.

Anecdotes also distort the risk. If someone starts berberine, develops abdominal pain, sees abnormal labs, or has a medication change at the same time, the supplement may get blamed or excused without enough information. Liver injury case reports around supplements are also hard to interpret when products contain multiple ingredients, undisclosed compounds, variable doses, or contaminants. That uncertainty should make people more careful, not more certain.

Social media adds another problem. Berberine became popular as a weight-loss and metabolic supplement, and NCCIH notes that online attention has run ahead of rigorous clinical evidence for some promoted uses.² When a supplement is hyped, backlash follows. “It is basically natural Ozempic” and “it will wreck your kidneys” are opposite claims, but they share the same flaw: they compress a complicated safety question into a slogan.

What is true nearby

The kernel of truth is that berberine deserves more respect than a casual multivitamin. It can cause gastrointestinal side effects. It may interact with medications. It should be avoided in infants, and pregnancy or breastfeeding are not the time to experiment with it.²

For someone with normal kidney and liver function, the practical concern is not that berberine is proven to damage those organs. It is whether you are using a reasonable dose, buying a tested product, avoiding risky combinations, and checking labs if you have medical conditions. For someone with severe kidney disease, dialysis, active liver disease, transplant history, or complex prescriptions, the standard changes. In that setting, “probably fine for healthy adults” is not good enough.

The myth is false as a blanket warning. The better rule is more precise: berberine does not look broadly kidney-toxic or liver-toxic in short human studies, but it is pharmacologically active and under-studied in the people most likely to need individualized safety advice.